Results 11 to 20 of about 12,297 (185)

Vulvar basal cell carcinoma

open access: yesIndian Journal of Pathology and Microbiology, 2012
Although the basal cell carcinoma (BCC) is the most common malignancy of skin, it is rarely seen in vulva and constitutes 2% to 4% of all vulvar cancers. The cause is unknown but, chronic vulvar irritation is the most important underlying factor.
Mustafa Kara   +2 more
doaj   +3 more sources

Carcinoma vulvar

open access: yesRevista Electrónica Dr. Zoilo E. Marinello Vidaurreta, 2015
El carcinoma de la vulva tiene una incidencia de aproximadamente un 3-5% dentro de todas las enfermedades ginecológicas malignas. El 90% de los tumores malignos de la vulva está constituido por carcinoma epidermoide, el resto son adenocarcinomas ...
Yamit Peñas Zayas   +2 more
doaj   +1 more source

Treatment patterns and outcomes in perineal primary vulvar cancer-a population-based Swedish cohort study. [PDF]

open access: yesActa Obstet Gynecol Scand
Perineal vulvar squamous cell carcinoma was identified in 147 of 571 cases. Owing to the anatomical proximity of these tumors to the anus, treatment selection may present considerable clinical challenges. The majority of patients (53%) underwent surgical treatment alone, whereas 23% received surgery combined with adjuvant radiotherapy and 24% were ...
Kjölhede K   +4 more
europepmc   +2 more sources

Sebaceous Carcinoma of the Vulva: A Case Report and Review of the Literature

open access: yesAvicenna Journal of Medicine, 2021
Sebaceous carcinoma is a rare malignant cutaneous neoplasm that is most commonly arises in the ocular region. Although it can occur in extraocular sites, sebaceous carcinoma is rarely encountered in the vulva.
Hind Alharthi   +3 more
doaj   +1 more source

Therapy for Primary Vulvar Carcinoma [PDF]

open access: yesGeburtshilfe und Frauenheilkunde, 2014
The rather rare vulvar cancer is almost always a squamous cell carcinoma that mostly develops from an underlying VIN or HPV infection. In addition, lichen sclerosus et atrophicans, immune deficiency, nicotine abuse or anogenital intraepithelial neoplasias may play a role in the pathogenesis.
D, Herr, I, Juhasz-Boess, E F, Solomayer
openaire   +2 more sources

Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma

open access: yesTumor Biology, 2017
The role of circulating microRNAs as a promising tool for diagnosing cancer and monitoring anticancer therapies has been widely studied in the past decades.
Kamil Zalewski   +9 more
doaj   +1 more source

Vulvar basal cell carcinoma, a rare location [PDF]

open access: yesJournal of Clinical and Investigative Surgery, 2018
Basal Cell Carcinoma is the most common human malignant neoplasm. Vulvar basal cell carcinoma is rare, accounting for less than 5% of all vulvar neoplasms.
Cornelia Nitipir   +5 more
doaj   +1 more source

Vulvar Paget disease secondary to high-grade urothelial carcinoma with underlying massive vascular embolization and cervical involvement: case report of unusual presentation

open access: yesDiagnostic Pathology, 2019
Background Vulvar extramammary Paget disease is a rare chronic condition, that presents with non-specific symptoms such as pruritus and eczematous lesions. Because most of these lesions are noninvasive, the distinction between primary and secondary Paget
Walquiria Quida Salles Pereira Primo   +5 more
doaj   +1 more source

Pilomatrix carcinoma of the vulva

open access: yesGynecologic Oncology Reports, 2016
Background: Pilomatrix carcinomas are rare, frequently occurring in older male patients. We report a case of vulvar pilomatrix carcinoma in a 30-year-old woman, the second known reported case occurring on the external genitalia.
Mihae Song   +3 more
doaj   +1 more source

Wound complications following vulvar excision for nonmalignant lesionsAJOG Global Reports at a Glance

open access: yesAJOG Global Reports, 2021
BACKGROUND: There is a paucity of literature regarding the outcomes following vulvar excision for nonmalignant lesions. This is a common procedure among gynecologists and gynecologic oncologists, and a body of evidence is warranted to guide clinical care
Glenn P. Boyles, MD   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy